USD 13.52
(-0.59%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 6.58 Million | 4.39 Million | 3.47 Million | 4.07 Million | 2.71 Million | 2.51 Million |
Net Income | 4.93 Million | 4.71 Million | 3.13 Million | 2.62 Million | 2.55 Million | 2.23 Million |
Depreciation & Amortization | 277.78 Thousand | 336.62 Thousand | 331.14 Thousand | 346.05 Thousand | 314.06 Thousand | 242.82 Thousand |
Deferred income taxes | -94.52 Thousand | 249.52 Thousand | -118.88 Thousand | -776.38 Thousand | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | -132.35 Thousand | 296.59 Thousand | -191.44 Thousand |
Other non-cash items | 1.36 Million | -229.52 Thousand | 794.75 Thousand | 2.7 Million | 175.4 Thousand | 715.05 Thousand |
Investing Cash Flow | -46.83 Million | -122.12 Million | 12.87 Million | -65.34 Million | -15.51 Million | -18.1 Million |
Investments in PPE | -125.37 Thousand | -66.67 Thousand | -3.08 Million | -93.84 Thousand | -695.5 Thousand | -400.77 Thousand |
Acquisitions | - | 117.16 Million | 6.09 Million | 3758.00 | 3.87 Million | - |
Investment purchases | -63.99 Million | -131.9 Million | -18.68 Million | -29.11 Million | -14.6 Million | -11.97 Million |
Sales/Maturities of investments | 16.48 Million | 14.73 Million | 15.59 Million | 14.49 Million | 10.73 Million | 3.9 Million |
Other Investing Activities | -46.7 Million | -122.06 Million | -491 Thousand | 382.7 Thousand | 1.29 Million | -17.7 Million |
Financing Cash Flow | 39.34 Million | 18.57 Million | 61.16 Million | 82.56 Million | 24.12 Million | 6.89 Million |
Debt repayment | -57 Million | - | - | -5 Million | -15 Million | -15 Million |
Dividends payments | -2594.00 | - | -2374.00 | - | -2344.00 | -3318.00 |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -17.65 Million | 18.57 Million | 61.16 Million | 77.56 Million | 9.13 Million | 6.89 Million |
Accounts receivables | - | - | - | - | -34.35 Thousand | -57.2 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | 356.99 Thousand | -134.23 Thousand |
Cash at beginning of period | 36.43 Million | 135.59 Million | 58.07 Million | 36.77 Million | 25.45 Million | 34.15 Million |
Cash at end of period | 35.52 Million | 36.43 Million | 135.59 Million | 58.07 Million | 36.77 Million | 25.45 Million |
Capital Expenditure | -125.37 Thousand | -66.67 Thousand | -3.08 Million | -93.84 Thousand | -695.5 Thousand | -400.77 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -907.08 Thousand | -99.15 Million | 77.51 Million | 21.29 Million | 11.32 Million | -8.7 Million |
Free Cash Flow | 6.45 Million | 4.32 Million | 392.66 Thousand | 3.98 Million | 2.01 Million | 2.11 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.23 Million | 1.24 Million | 1.22 Million | 4.93 Million | 1.27 Million | 1.26 Million |
Depreciation & Amortization | - | - | - | 277.78 Thousand | - | - |
Deferred income taxes | - | - | - | -94.52 Thousand | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -1.23 Million | -1.24 Million | -1.22 Million | 2.01 Million | -1.27 Million | -1.26 Million |
Investing Cash Flow | - | - | - | -46.83 Million | - | - |
Investments in PPE | - | - | - | -125.37 Thousand | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | -63.99 Million | - | - |
Sales/Maturities of investments | - | - | - | 16.48 Million | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | 39.34 Million | - | - |
Debt repayment | - | - | - | -57 Million | - | - |
Dividends payments | - | - | - | -2594.00 | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | 36.43 Million | - | - |
Cash at end of period | - | - | - | 36.43 Million | - | - |
Capital Expenditure | - | - | - | -125.37 Thousand | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | - | - | - | 6.45 Million | - | - |
SSUMF
0RNP
SHWGY
DRMA
TROX
000678